223 related articles for article (PubMed ID: 36975162)
1. Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Mok TH; Nihat A; Majbour N; Sequeira D; Holm-Mercer L; Coysh T; Darwent L; Batchelor M; Groveman BR; Orr CD; Hughson AG; Heslegrave A; Laban R; Veleva E; Paterson RW; Keshavan A; Schott JM; Swift IJ; Heller C; Rohrer JD; Gerhard A; Butler C; Rowe JB; Masellis M; Chapman M; Lunn MP; Bieschke J; Jackson GS; Zetterberg H; Caughey B; Rudge P; Collinge J; Mead S
Brain; 2023 Jun; 146(6):2570-2583. PubMed ID: 36975162
[TBL] [Abstract][Full Text] [Related]
2. Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.
Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisakk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather LE; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
Neurology; 2024 Jul; 103(2):e209506. PubMed ID: 38896810
[TBL] [Abstract][Full Text] [Related]
3. Biomarker changes preceding symptom onset in genetic prion disease.
Vallabh SM; Mortberg MA; Allen SW; Kupferschmid AC; Kivisäkk P; Hammerschlag BL; Bolling A; Trombetta BA; Devitte-McKee K; Ford AM; Sather L; Duffy G; Rivera A; Gerber J; McManus AJ; Minikel EV; Arnold SE
medRxiv; 2023 Dec; ():. PubMed ID: 38196583
[TBL] [Abstract][Full Text] [Related]
4. Early detection of abnormal prion protein in genetic human prion diseases now possible using real-time QUIC assay.
Sano K; Satoh K; Atarashi R; Takashima H; Iwasaki Y; Yoshida M; Sanjo N; Murai H; Mizusawa H; Schmitz M; Zerr I; Kim YS; Nishida N
PLoS One; 2013; 8(1):e54915. PubMed ID: 23372790
[TBL] [Abstract][Full Text] [Related]
5. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
6. Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt-Jakob Disease in Denmark.
Bsoul R; Lund EL; Burns K; Andrews M; McKenzie N; Green A; Areškevičiūtė A
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047069
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
Vallabh SM; Minikel EV; Williams VJ; Carlyle BC; McManus AJ; Wennick CD; Bolling A; Trombetta BA; Urick D; Nobuhara CK; Gerber J; Duddy H; Lachmann I; Stehmann C; Collins SJ; Blennow K; Zetterberg H; Arnold SE
BMC Med; 2020 Jun; 18(1):140. PubMed ID: 32552681
[TBL] [Abstract][Full Text] [Related]
9. Large-scale validation of skin prion seeding activity as a biomarker for diagnosis of prion diseases.
Zhang W; Orrú CD; Foutz A; Ding M; Yuan J; Shah SZA; Zhang J; Kotobelli K; Gerasimenko M; Gilliland T; Chen W; Tang M; Cohen M; Safar J; Xu B; Hong DJ; Cui L; Hughson AG; Schonberger LB; Tatsuoka C; Chen SG; Greenlee JJ; Wang Z; Appleby BS; Caughey B; Zou WQ
Acta Neuropathol; 2024 Jan; 147(1):17. PubMed ID: 38231266
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Human Prion Disease Using Real-Time Quaking-Induced Conversion Testing of Olfactory Mucosa and Cerebrospinal Fluid Samples.
Bongianni M; Orrù C; Groveman BR; Sacchetto L; Fiorini M; Tonoli G; Triva G; Capaldi S; Testi S; Ferrari S; Cagnin A; Ladogana A; Poleggi A; Colaizzo E; Tiple D; Vaianella L; Castriciano S; Marchioni D; Hughson AG; Imperiale D; Cattaruzza T; Fabrizi GM; Pocchiari M; Monaco S; Caughey B; Zanusso G
JAMA Neurol; 2017 Feb; 74(2):155-162. PubMed ID: 27942718
[TBL] [Abstract][Full Text] [Related]
12. Rapid and sensitive RT-QuIC detection of human Creutzfeldt-Jakob disease using cerebrospinal fluid.
Orrú CD; Groveman BR; Hughson AG; Zanusso G; Coulthart MB; Caughey B
mBio; 2015 Jan; 6(1):. PubMed ID: 25604790
[TBL] [Abstract][Full Text] [Related]
13. Real-time quaking-induced conversion assays for prions: Applying a sensitive but imperfect test in clinical practice.
Jones SM; Lazar EB; Porter AL; Prusinski CC; Brier MR; Bucelli RC; Day GS
Eur J Neurol; 2023 Jul; 30(7):1854-1860. PubMed ID: 36940265
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.
Schmitz M; Villar-Piqué A; Hermann P; Escaramís G; Calero M; Chen C; Kruse N; Cramm M; Golanska E; Sikorska B; Liberski PP; Pocchiari M; Lange P; Stehmann C; Sarros S; Martí E; Baldeiras I; Santana I; Žáková D; Mitrová E; Dong XP; Collins S; Poleggi A; Ladogana A; Mollenhauer B; Kovacs GG; Geschwind MD; Sánchez-Valle R; Zerr I; Llorens F
Brain; 2022 Apr; 145(2):700-712. PubMed ID: 35288744
[TBL] [Abstract][Full Text] [Related]
15. Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases.
Mok TH; Nihat A; Luk C; Sequeira D; Batchelor M; Mead S; Collinge J; Jackson GS
Sci Rep; 2021 Mar; 11(1):5231. PubMed ID: 33664355
[TBL] [Abstract][Full Text] [Related]
16. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD.
Fiorini M; Iselle G; Perra D; Bongianni M; Capaldi S; Sacchetto L; Ferrari S; Mombello A; Vascellari S; Testi S; Monaco S; Zanusso G
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019068
[TBL] [Abstract][Full Text] [Related]
17. Characteristic CSF prion seeding efficiency in humans with prion diseases.
Cramm M; Schmitz M; Karch A; Zafar S; Varges D; Mitrova E; Schroeder B; Raeber A; Kuhn F; Zerr I
Mol Neurobiol; 2015 Feb; 51(1):396-405. PubMed ID: 24809690
[TBL] [Abstract][Full Text] [Related]
18. Review: Fluid biomarkers in the human prion diseases.
Thompson AGB; Mead SH
Mol Cell Neurosci; 2019 Jun; 97():81-92. PubMed ID: 30529227
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.
Saijo E; Groveman BR; Kraus A; Metrick M; Orrù CD; Hughson AG; Caughey B
Methods Mol Biol; 2019; 1873():19-37. PubMed ID: 30341601
[TBL] [Abstract][Full Text] [Related]
20. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
